Inlecitug
Inlecitug is a chimeric monoclonal antibody targeting human KDR (kinase insert domain receptor) . Inlecitug specifically binds to KDR, blocking the binding of vascular endothelial growth factor (VEGF) to KDR and inhibiting angiogenesis, thus exerting antitumor activity. Inlecitug is promising for research of cancers[1].
Product Specifications
CAS Number
[2997627-68-4]
UNSPSC
12352203
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[Inlecitug]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal CD90/Thy1 Antibody (Thy-1A1) [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
